Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CPHI vs CNET

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CPHI
China Pharma Holdings, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareAMEX • CN
Market Cap$9M
5Y Perf.-99.8%
CNET
ZW Data Action Technologies Inc.

Advertising Agencies

Communication ServicesNASDAQ • CN
Market Cap$2M
5Y Perf.-96.1%

CPHI vs CNET — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CPHI logoCPHI
CNET logoCNET
IndustryDrug Manufacturers - Specialty & GenericAdvertising Agencies
Market Cap$9M$2M
Revenue (TTM)$4M$6M
Net Income (TTM)$-3M$-2M
Gross Margin-8.4%4.8%
Operating Margin-79.8%-31.7%
Total Debt$4M$122K
Cash & Equiv.$627K$812K

CPHI vs CNETLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CPHI
CNET
StockMay 20May 26Return
China Pharma Holdin… (CPHI)1000.2-99.8%
ZW Data Action Tech… (CNET)1003.9-96.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: CPHI vs CNET

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CNET leads in 3 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. China Pharma Holdings, Inc. is the stronger pick specifically for growth and revenue expansion and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CPHI
China Pharma Holdings, Inc.
The Income Pick

CPHI is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 1.18
  • Rev growth -35.4%, EPS growth 6.9%, 3Y rev CAGR -22.3%
  • -35.4% revenue growth vs CNET's -49.5%
Best for: income & stability and growth exposure
CNET
ZW Data Action Technologies Inc.
The Long-Run Compounder

CNET carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • -97.8% 10Y total return vs CPHI's -99.5%
  • Lower volatility, beta 1.18, Low D/E 3.3%, current ratio 1.57x
  • Beta 1.18, current ratio 1.57x
Best for: long-term compounding and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthCPHI logoCPHI-35.4% revenue growth vs CNET's -49.5%
Quality / MarginsCNET logoCNET-33.4% margin vs CPHI's -78.7%
Stability / SafetyCNET logoCNETBeta 1.18 vs CPHI's 1.18, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)CNET logoCNET-55.1% vs CPHI's -71.9%
Efficiency (ROA)CPHI logoCPHI-20.0% ROA vs CNET's -21.3%, ROIC -32.2% vs -64.7%

CPHI vs CNET — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CPHIChina Pharma Holdings, Inc.
FY 2021
DomesticPharmaceuticalsMember
100.0%$10M
CNETZW Data Action Technologies Inc.
FY 2024
Search Engine Marketing and Data Service
67.5%$10M
Online Advertising Placement
32.5%$5M

CPHI vs CNET — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCNETLAGGINGCPHI

Income & Cash Flow (Last 12 Months)

CNET leads this category, winning 4 of 6 comparable metrics.

CNET is the larger business by revenue, generating $6M annually — 1.5x CPHI's $4M. CNET is the more profitable business, keeping -33.4% of every revenue dollar as net income compared to CPHI's -78.7%. On growth, CPHI holds the edge at -31.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCPHI logoCPHIChina Pharma Hold…CNET logoCNETZW Data Action Te…
RevenueTrailing 12 months$4M$6M
EBITDAEarnings before interest/tax-$2M-$2M
Net IncomeAfter-tax profit-$3M-$2M
Free Cash FlowCash after capex-$129,606-$2M
Gross MarginGross profit ÷ Revenue-8.4%+4.8%
Operating MarginEBIT ÷ Revenue-79.8%-31.7%
Net MarginNet income ÷ Revenue-78.7%-33.4%
FCF MarginFCF ÷ Revenue-3.2%-27.3%
Rev. Growth (YoY)Latest quarter vs prior year-31.3%-47.0%
EPS Growth (YoY)Latest quarter vs prior year+26.1%+95.7%
CNET leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CNET leads this category, winning 2 of 3 comparable metrics.
MetricCPHI logoCPHIChina Pharma Hold…CNET logoCNETZW Data Action Te…
Market CapShares × price$9M$2M
Enterprise ValueMkt cap + debt − cash$12M$1M
Trailing P/EPrice ÷ TTM EPS-1.95x-0.38x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue2.03x0.12x
Price / BookPrice ÷ Book value/share1.19x0.38x
Price / FCFMarket cap ÷ FCF
CNET leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

Evenly matched — CPHI and CNET each lead in 4 of 8 comparable metrics.

CPHI delivers a -37.6% return on equity — every $100 of shareholder capital generates $-38 in annual profit, vs $-60 for CNET. CNET carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to CPHI's 0.46x. On the Piotroski fundamental quality scale (0–9), CNET scores 5/9 vs CPHI's 2/9, reflecting solid financial health.

MetricCPHI logoCPHIChina Pharma Hold…CNET logoCNETZW Data Action Te…
ROE (TTM)Return on equity-37.6%-60.3%
ROA (TTM)Return on assets-20.0%-21.3%
ROICReturn on invested capital-32.2%-64.7%
ROCEReturn on capital employed-47.0%-73.5%
Piotroski ScoreFundamental quality 0–925
Debt / EquityFinancial leverage0.46x0.03x
Net DebtTotal debt minus cash$3M-$690,000
Cash & Equiv.Liquid assets$626,879$812,000
Total DebtShort + long-term debt$4M$122,000
Interest CoverageEBIT ÷ Interest expense-28.22x
Evenly matched — CPHI and CNET each lead in 4 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

CNET leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CNET five years ago would be worth $206 today (with dividends reinvested), compared to $16 for CPHI. Over the past 12 months, CNET leads with a -55.1% total return vs CPHI's -71.9%. The 3-year compound annual growth rate (CAGR) favors CNET at -52.1% vs CPHI's -69.5% — a key indicator of consistent wealth creation.

MetricCPHI logoCPHIChina Pharma Hold…CNET logoCNETZW Data Action Te…
YTD ReturnYear-to-date-56.5%-44.4%
1-Year ReturnPast 12 months-71.9%-55.1%
3-Year ReturnCumulative with dividends-97.2%-89.0%
5-Year ReturnCumulative with dividends-99.8%-97.9%
10-Year ReturnCumulative with dividends-99.5%-97.8%
CAGR (3Y)Annualised 3-year return-69.5%-52.1%
CNET leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CNET leads this category, winning 2 of 2 comparable metrics.

CNET is the less volatile stock with a 1.18 beta — it tends to amplify market swings less than CPHI's 1.18 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CNET currently trades 25.2% from its 52-week high vs CPHI's 20.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCPHI logoCPHIChina Pharma Hold…CNET logoCNETZW Data Action Te…
Beta (5Y)Sensitivity to S&P 5001.18x1.18x
52-Week HighHighest price in past year$2.60$2.78
52-Week LowLowest price in past year$0.50$0.57
% of 52W HighCurrent price vs 52-week peak+20.2%+25.2%
RSI (14)Momentum oscillator 0–10035.150.7
Avg Volume (50D)Average daily shares traded26K11K
CNET leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

CPHI leads this category, winning 1 of 1 comparable metric.
MetricCPHI logoCPHIChina Pharma Hold…CNET logoCNETZW Data Action Te…
Analyst RatingConsensus buy/hold/sell
Price TargetConsensus 12-month target
# AnalystsCovering analysts
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises10
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
CPHI leads this category, winning 1 of 1 comparable metric.
Key Takeaway

CNET leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). CPHI leads in 1 (Analyst Outlook). 1 tied.

Best OverallZW Data Action Technologies… (CNET)Leads 4 of 6 categories
Loading custom metrics...

CPHI vs CNET: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is CPHI or CNET a better buy right now?

For growth investors, China Pharma Holdings, Inc.

(CPHI) is the stronger pick with -35. 4% revenue growth year-over-year, versus -49. 5% for ZW Data Action Technologies Inc. (CNET). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — CPHI or CNET?

Over the past 5 years, ZW Data Action Technologies Inc.

(CNET) delivered a total return of -97. 9%, compared to -99. 8% for China Pharma Holdings, Inc. (CPHI). Over 10 years, the gap is even starker: CNET returned -97. 8% versus CPHI's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — CPHI or CNET?

By beta (market sensitivity over 5 years), ZW Data Action Technologies Inc.

(CNET) is the lower-risk stock at 1. 18β versus China Pharma Holdings, Inc. 's 1. 18β — meaning CPHI is approximately 0% more volatile than CNET relative to the S&P 500. On balance sheet safety, ZW Data Action Technologies Inc. (CNET) carries a lower debt/equity ratio of 3% versus 46% for China Pharma Holdings, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — CPHI or CNET?

By revenue growth (latest reported year), China Pharma Holdings, Inc.

(CPHI) is pulling ahead at -35. 4% versus -49. 5% for ZW Data Action Technologies Inc. (CNET). On earnings-per-share growth, the picture is similar: China Pharma Holdings, Inc. grew EPS 6. 9% year-over-year, compared to -124. 1% for ZW Data Action Technologies Inc.. Over a 3-year CAGR, CPHI leads at -22. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — CPHI or CNET?

ZW Data Action Technologies Inc.

(CNET) is the more profitable company, earning -24. 4% net margin versus -104. 6% for China Pharma Holdings, Inc. — meaning it keeps -24. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CNET leads at -24. 3% versus -101. 3% for CPHI. At the gross margin level — before operating expenses — CNET leads at 2. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — CPHI or CNET?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is CPHI or CNET better for a retirement portfolio?

For long-horizon retirement investors, ZW Data Action Technologies Inc.

(CNET) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 18)). Both have compounded well over 10 years (CNET: -97. 8%, CPHI: -99. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between CPHI and CNET?

These companies operate in different sectors (CPHI (Healthcare) and CNET (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CPHI

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

CNET

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CPHI and CNET on the metrics below

Revenue Growth>
%
(CPHI: -31.3% · CNET: -47.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.